John C. McKew
2020
In 2020, John C. McKew earned a total compensation of $1.2M as Chief Scientific and Chief Operating Officer at NewLink Genetics, a 119% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $276,044 |
---|---|
Option Awards | $365,475 |
Salary | $436,300 |
Stock Awards | $102,310 |
Other | $35,641 |
Total | $1,215,770 |
McKew received $436.3K in salary, accounting for 36% of the total pay in 2020.
McKew also received $276K in non-equity incentive plan, $365.5K in option awards, $102.3K in stock awards and $35.6K in other compensation.
Rankings
In 2020, John C. McKew's compensation ranked 7,781st out of 13,090 executives tracked by ExecPay. In other words, McKew earned more than 40.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,781 | 41st |
Manufacturing | 3,281 | 42nd |
Chemicals And Allied Products | 1,330 | 41st |
Drugs | 1,153 | 41st |
Pharmaceutical Preparations | 857 | 41st |
McKew's colleagues
We found five more compensation records of executives who worked with John C. McKew at NewLink Genetics in 2020.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021
NewLink Genetics Former Chief Executive & Scientific Officer Charles Link's 2019 pay falls 38% to $1.7M
June 23, 2020